Bone marrow transplantation for chronic granulocytic leukaemia. 1985

H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann

Twenty-one patients with chronic granulocytic leukaemia underwent marrow transplantation. The donors were human-lymphocyte antigen-identical siblings in 19 cases. In the remaining 2 cases the donor was a parent in one and an identical twin in the other. The preparatory regimen included cyclophosphamide and 8.6 Gy total body irradiation given at either a dose of 0.1 Gy/min or 0.04 Gy/min. Five patients were in the accelerated phase of the disease, one was in remission following blast crisis, and the rest were all in the chronic phase. After chemotherapy and irradiation, all patients received bone marrow transplants. To date, nine patients are still alive, with a median survival of 64 days (range 28-683 days). One patient continued to have leukaemic cells and in another, the leukaemia recurred 18 months following transplantation. Interstitial pneumonitis was the cause of death of eight patients (38%). Graft-versus-host disease occurred in ten patients (47%).

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
October 1983, Clinics in haematology,
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
June 1983, Lancet (London, England),
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
January 1986, Lancet (London, England),
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
January 1987, Haematologica,
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
June 1986, Journal of the National Cancer Institute,
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
November 1986, Cancer,
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
October 1982, British journal of haematology,
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
November 1987, British journal of haematology,
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
November 1981, Experimental hematology,
H K Mahmoud, and U W Schaefer, and F Schüning, and D Beelen, and R Becher, and C G Schmidt, and W Alberti, and E Haralambie, and G Linzenmeier, and B Stollmann
April 1987, Bone marrow transplantation,
Copied contents to your clipboard!